Low-dose inhaled nitric oxide in acutely burned children with profound respiratory failure

Surgery

Volumn 126, Issue 5, 1999, Pages 856-862

  Sheridan, Robert L ^a,b   Zapol, Warren M ^b   Ritz, Ray H ^b   Tompkins, Ronald G ^b  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; OXYGEN;

ADOLESCENT; ARTERIAL OXYGEN TENSION; ARTICLE; BURN; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HEART RIGHT LEFT SHUNT; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE; SURVIVAL; TREATMENT OUTCOME;

EID: 0032740466     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(99)70026-7     Document Type: Article

References (62)

1. 1. Hollingsed TC, Saffle JR, Barton RG, Craft WB, Morris SE. Etiology and consequences of respiratory failure in thermally injured patients. Am J Surg 1993;166:592-6.
2. 2. Pruitt BA Jr, Cioffi WG, Shimazu T, Ikeuchi H, Mason AD Jr. Evaluation and management of patients with inhalation injury. J Trauma 1990;30:S63-8.
3. 3. Fitzpatrick JC, Cioffi WG Jr, Cheu HW, Pruitt BA Jr. Predicting ventilation failure in children with inhalation injury. J Pediatr Surg 1994;29:1122-6.
4. 4. Moore FA, Moore EE, Read RA. Postinjury multiple organ failure: role of extrathoracic injury and sepsis in adult respiratory distress syndrome. New Horizons 1993;1:538-49.
5. 5. Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema: respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988;137:1159-64.
6. 6. Corbridge TC, Wood LD, Crawford GP, Chudoba MJ, Yanos J, Sznajder JI. Adverse effects of large tidal volume and low PEEP in canine acid aspiration. Am Rev Respir Dis 1990;142:311-5.
7. 7. Webb HH, Tierney DF. Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures: protection by positive end-expiratory pressure. Am Rev Respir Dis 1974;110:556-65.
8. 8. Barber RE, Hamilton WR. Oxygen toxicity in man. N Engl J Med 1970;283:1478-84.
9. 9. Toor AH, Tomashefski JF Jr, Kleinerman J. Respiratory tract pathology in patients with severe burns. Hum Pathol 1990;21:1212-20.
10. 10. Zapol WM, Snider MT. Pulmonary hypertension in severe acute respiratory failure. N Engl J Med 1977;296:476-80.
11. 11. Zapol WM, Jones R. Vascular components of ARDS: clinical pulmonary hemodynamics and morphology. Am Rev Respir Dis 1987;136:471-4.
12. 12. Tomashefski JF Jr, Davies P, Boggis C, Greene R, Zapol WM, Reid LM. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol 1983;112:112-26.
13. 13. Ring JC, Stidham GL. Novel therapies for acute respiratory failure. Pediatr Clin North Am 1994;41:1325-63.
14. 14. Ignarro LJ, Buga GM, Byrns RE, Wood KS, Chaudhuri G. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle. J Pharmacol Exper Ther 1988;246:218-26.
15. 15. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
16. 16. Ignarro LJ, Ross G, Tillisch J. Pharmacology of endothelium-derived nitric oxide and nitrovasodilators. West J Med 1991;154:51-62.
17. 17. Hutchison AA. Respiratory disorders of the neonate. Curr Opin Pediatr 1994;6:142-53.
18. 18. Roberts JD Jr, Shaul PW. Advances in the treatment of persistent pulmonary hypertension of the newborn. Pediatr Clin North Am 1993;40:983-1004.
19. 19. Roberts JD Jr, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1993;87:417-53.
20. 20. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:818-9.
21. 21. Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA. Inhaled nitric oxide in infants referred for extra-corporeal membrane oxygenation: dose response. J Pediatr 1994;124:302-8.
22. 22. Sheridan RL, Hurford WE, Kacmarek RM, et al. Inhaled nitric oxide in burn patients with respiratory failure. J Trauma 1997;42:629-34.
23. 23. Bone RC, Maunder R, Slotman G, et al. An early test of survival in patients with the adult respiratory distress syndrome: the PaO2/Flo2 ratio and its differential response to conventional therapy - Prostaglandin E1 Study Group. Chest 1989;96:849-51.
24. 24. Graves TA, Cioffi WG, McManus WF, Mason AD Jr, Pruitt BA Jr. Fluid resuscitation of infants and children with massive thermal injury. J Trauma 1988;28:1656-9.
25. 25. Sheridan RL. The seriously burned child: resuscitation through reintegration - 1. Curr Probl Pediatr 1998;28:105-27.
26. 26. Sheridan RL. The seriously burned child: resuscitation through reintegration - 2. Curr Probl Pediatr 1998;28:139-67.
27. 27. Sheridan RL, Tompkins RG, Burke JF. Management of burn wounds with prompt excision and immediate closure. J Intensive Care Med 1994;9:6-19.
28. 28. Cunningham JJ, Lydon MK, Russell WE. Calorie and protein provision for recovery from severe burns in infants and young children. Am J Clin Nutr 1990;51:553-7.
29. 29. Sheridan RL, Kacmarek RM, McEurick MM, et al. Permissive hypercapnia as a ventilatory strategy in burned children: effect on barotrauma, pneumonia, and mortality. J Trauma 1995;39:854-9.
30. 30. Kacmarek RM, Hickling KG. Permissive hypercapnia. Respir Care 1993;38:373-87.
31. 31. Nishimura M, Hess D, Kacmarek RM, Ritz R, Hurford WE. Nitrogen dioxide production during mechanical ventilation with nitric oxide in adults: effects of ventilator internal volume, air versus nitrogen dilution, minute ventilation, and inspired oxygen fraction. Anesthesiology 1995;82:1246-54.
32. 32. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138:720-3.
33. 33. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-8.
34. 34. Hurford WE, Zapol WM. The right ventricle and critical illness: a review of anatomy, physiology, and clinical evaluation of its function. Intensive Care Medicine 1988;14(suppl 2):448-57.
35. 35. Page RD, Harringer W, Hodakowski GT, et al. Determinants of maximal right ventricular function. J Heart Lung Transplant 1992;11:90-8.
36. 36. Sibbald WJ, Driedger AA, Myers ML, Short AI, Wells GA. Biventricular function in the adult respiratory distress syndrome. Chest 1983;84:126-34.
37. 37. Erdmann AJ 3d, Vaughan TR Jr, Brigham KL, Woolverton WC, Staub NC. Effect of increased vascular pressure on lung fluid balance in unanesthetized sheep. Circ Res 1975;37:271-84.
38. 38. Melot C, Lejeune P, Leeman M, Moraine JJ, Naeije R. Prostaglandin E1 in the adult respiratory distress syndrome: benefit for pulmonary hypertension and cost for pulmonary gas exchange. Am Rev Respir Dis 1989;139:106-10.
39. 39. Dupuy PM, Shore SA, Drazen JM, Frostell C, Hill WA, Zapol WM. Bronchodilator action of inhaled nitric oxide in guinea pigs. J Clin Invest 1992;90:421-8.
40. 40. Kacmarek RM, Ripple R, Cockrill BA, Bloch KJ, Zapol WM, Johnson DC. Inhaled nitric oxide: a bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am J Respir Crit Care Med 1996;153:128-35.
41. 41. Rovira I, Chen TY, Winkler M, Kawai N, Bloch KD, Zapol WM. Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J Appl Physiol 1994;76:345-55.
42. 42. Roberts JD Jr, Roberts CT, Jones RC, Zapol WM, Bloch KD. Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ Res 1995;76:215-22.
43. 43. Roberts JD Jr, Chen TY, Kawai N, et al. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ Res 1993;72:246-54.
44. 44. Fratacci MD, Frostell CG, Chen TY, Wain JC Jr, Robinson DR, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 1991;75:990-9.
45. 45. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-47.
46. 46. Ogura H, Cioffi WG, Offner PJ, Jordan BS, Johnson AA, Pruitt BA Jr. Effect of inhaled nitric oxide on pulmonary function after sepsis in a swine model. Surgery 1994;116:313-21.
47. 47. Ogura H, Cioffi WG Jr, Jordan BS, et al. The effect of inhaled nitric oxide on smoke inhalation injury in an ovine model. J Trauma 1994;37:294-301.
48. 48. Zapol WM, Falke KJ, Hurford WE, Roberts JD Jr. Inhaling nitric oxide: a selective pulmonary vasodilator and bronchodilator. Chest 1994;105:87S-91S.
49. 49. Bigatello LM, Hurford WE, Kacmarek RM, Roberts JD Jr, Zapol WM. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome: effects on pulmonary hemodynamics and oxygenation. Anesthesiology 1994;80:761-70.
50. 50. Radermacher P, Santak B, Wust HJ, Tarnow J, Falke KJ. Prostacyclin and right ventricular function in patients with pulmonary hypertension associated with ARDS. Intensive Care Med 1990;16:227-32.
51. 51. Radermacher P, Santak B, Wust HJ, Tarnow J, Falke KJ. Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology 1990;72:238-44.
52. 52. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
53. 53. Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 1993;78:427-35.
54. 54. Gerlach H, Rossaint R, Pappert D, Falke KJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993;23:499-502.
55. 55. Semigran MJ, Cockrill BA, Kacmarek R, et al. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol 1994;24:982-8.
56. 56. Ricou B, Grandin S, Jolliet P, Chevrolet JC, Suter PM. Nitrous oxide (NO) in the treatment of adult respiratory distress syndrome [in French]. Schweiz Med Wochenschr 1994;14:583-8.
57. 57. McIntyre RC, Moore FA, Moore EE, Piedalue F, Haenel JS, Fullerton DA. Inhaled nitric oxide variably improves oxygenation and pulmonary hypertension in patients with acute respiratory distress syndrome. J Trauma 1995;39:418-25.
58. 58. Oda H, Nogami H, Kusumoto S, Nakajima T, Kurata A. Lifetime exposure to 2.4 ppm nitric oxide in mice. Environ Res 1980;22:254-63.
59. 59. Levy B, Bollaert PE, Bauer P, Nace L, Audibert G, Larcan A. Therapeutic optimization including inhaled nitric oxide in adult respiratory distress syndrome in a polyvalent intensive care unit. J Trauma 1995;38:370-4.
60. 60. Slutsky AS. Mechanical ventilation: American College of Chest Physicians' Consensus Conference. Chest 1993;104: 1833-59.
61. 61. Hickling KG, Walsh J, Henderson S, Jackson R. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med 1994;22:1568-78.
62. 62. McIntyre RC Jr, Haenel JB, Moore FA, Read RR, Burch JM, Moore EE. Cardiopulmonary effects of permissive hypercapnia in the management of adult respiratory distress syndrome. J Trauma 1994;37:433-8.